Aquí encontrarán algunos de los artículos científicos que he publicado como resultado de mi trabajo de investigadora en el área de la inmunología humana.

  • Cuapio A, Boulouis C, Filipovic I, Wullimann D, Kammann T, Parrot T, et al. NK cell frequencies, function and correlates to vaccine outcome in BNT162b2 mRNA anti-SARS-CoV-2 vaccinated healthy and immunocompromised individuals. Mol Med. 2022;28(1):20

  • Healy K, Pin E, Chen P, Soderdahl G, Nowak P, Mielke S, Cuapio A, et al. Salivary IgG to SARS-CoV-2 indicates seroconversion and correlates to serum neutralization in mRNA-vaccinated immunocompromised individuals. Med (N Y). 2022;3(2):137-53 e3.

  • Blixt L, Wullimann D, Aleman S, Lundin J, Chen P, Gao Y, Cuapio A, et al. T cell immune responses following vaccination with mRNA BNT162b2 against SARS-CoV-2 in patients with chronic lymphocytic leukemia: results from a prospective open-label clinical trial. Haematologica. 2022.

  • Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11(1):16144.

  • Cuapio A, Ljunggren HG. Activated Natural Killer Cells Hit Neurogenesis in the Aging Brain. Neurosci Bull. 2021;37(7):1072-4.

  • Medina-Enriquez MM, Lopez-Leon S, Carlos-Escalante JA, Aponte-Torres Z, Cuapio A, Wegman-Ostrosky T. ACE2: the molecular doorway to SARS-CoV-2. Cell Biosci. 2020;10(1):148.

  • Maucourant C, Filipovic I, Ponzetta A, Aleman S, Cornillet M, Hertwig L, Cuapio A, et al. Natural killer cell immunotypes related to COVID-19 disease severity. Sci Immunol. 2020;5(50).
  • Blom K, Cuapio A, Sandberg JT, Varnaite R, Michaelsson J, Bjorkstrom NK, et al. Cell-Mediated Immune Responses and Immunopathogenesis of Human Tick-Borne Encephalitis Virus-Infection. Front Immunol. 2018;9:2174.

  • 1. Post M, Cuapio A, Osl M, Lehmann D, Resch U, Davies DM, et al. The Transcription Factor ZNF683/HOBIT Regulates Human NK-Cell Development. Front Immunol. 2017;8:535.

  • Michel T, Poli A, Cuapio A, Briquemont B, Iserentant G, Ollert M, et al. Human CD56bright NK Cells: An Update. J Immunol. 2016;196(7):2923-31.

  • Cuapio A, Post M, Cerny-Reiterer S, Gleixner KV, Stefanzl G, Basilio J, et al. Maintenance therapy with histamine plus IL-2 induces a striking expansion of two CD56bright NK cell subpopulations in patients with acute myeloid leukemia and supports their activation. Oncotarget. 2016;7(29):46466-81.

  • Rissiek A, Baumann I, Cuapio A, Mautner A, Kolster M, Arck PC, et al. The expression of CD39 on regulatory T cells is genetically driven and further upregulated at sites of inflammation. J Autoimmun. 2015;58:12-20.

  • Gur C, Ibrahim Y, Isaacson B, Yamin R, Abed J, Gamliel M, Cuapio A, et al. Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. Immunity. 2015;42(2):344-55

A %d blogueros les gusta esto: